Deborah H. Telman - 25 Jul 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
25 Jul 2023
Net transactions value
-$322,358
Form type
4
Filing time
26 Jul 2023, 16:53:55 UTC
Previous filing
26 May 2023
Next filing
26 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +8,231 +2189% 8,607 25 Jul 2023 Direct F1
transaction GILD Common Stock Tax liability $322,358 -4,174 -48% $77.23 4,433 25 Jul 2023 Direct
transaction GILD Common Stock Options Exercise +2,058 +46% 6,491 25 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -8,231 -19% 34,909 25 Jul 2023 Common Stock 8,231 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -2,058 -5.9% 32,851 25 Jul 2023 Common Stock 2,058 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.